BUDGET IMPACT ANALYSIS OF P4HB VS PERMANENT SYNTHETIC MESHES IN COMPLEX ABDOMINAL WALL REPAIR IN SPAIN
Author(s)
Busutil R1, Tripodi D2, Corral M3
1Bard España SA, Barcelona, Spain, 2C.R. Bard Inc, Warwick, RI, USA, 3C.R. Bard Inc., Murray Hill, ON, Canada
OBJECTIVES: Despite advances in surgical technique and prosthetic technologies, the risks for recurrence and infection are high following the repair of incisional ventral hernias. The current standard for reinforced hernia repair is synthetic mesh, which may reduce the risk for recurrence in many patients. Patients with comorbidities, contaminated wounds or previous wound infections experience higher rates of surgical site occurrences/infections (SSO/SSI). Mesh choice in Complex Abdominal Wall Repair (CAWR) may have an impact on short and long-term patient outcomes. The aim of this study was to analyze the economic consequences of P4HB Mesh use versus Permanent Synthetic Meshes in CAWR, under the perspective of the Spanish National Health System METHODS: A dynamic excel-based decision-analytic model was developed to assess the Budget Impact of P4HB Mesh in Complex Abdominal Wall Repair. For each comparator, variables of efficiency were set as Hernia Recurrence, Infected Mesh Explantation, Surgical Site Infection and Seroma. The analysis covered a 12 month time horizon and assumed 100% use for each technology. Public databases, as well as published and grey literature were used to estimate model input data. In the base case, a price difference of +1,500€ for P4HB mesh was considered. A tornado analysis was conducted for verification RESULTS: Compared to Permanent Synthetic meshes, use of P4HB mesh in CAWR resulted in cost savings of 364€ per procedure in Spain. The sensitivity analysis showed robust results for P4HB mesh, even in the most complex scenarios. CONCLUSIONS: Compared to Permanent Synthetic meshes, use of P4HB mesh may lead to potential cost savings in CAWR, under the perspective of the Spanish Health System. Further research is needed in order to better assess rates of clinical complications, as well as the appropriate patient groups where P4HB technology would be most beneficial for patients and health systems
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PMD138
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Multiple Diseases